2Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome [ J ]. Science, 2002,298 ( 5600 ) : 1912-1934..
3Bachmann M, M-,r-y T. The serine/threonine kinase PIM-1[J]. Int J Biochem Cell Biol,2005,37(4) :726-730.
4Mukaida N, Wang YY, Li YY. Roles of PIM-3, a novel survival kinase in tumorigenesis [ J ]. Cancer Sci,2011,102 (8) : 1437-1442.
5Mochizuki T, Kitanaka C, Noguchi K, et al. Physical and functional interactions between PIM-1 kinase and Cdc25A phosphatase. Implications for the PIM-1 -mediated activation of the c-Myc signaling pathway [ J ]. J Biol Chem, 1999,274(26): 18659-18666.
6Wang Z, Bhattacharya N, Mixter PF, et al. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by PIM-1 kinase[ J]. Biochim Biophys Acta,2002,1593 ( 1 ) :45-55.
7Bachmann M, Hennemann H, Xing PX, et al. The oncogenic serine/threonine kinase PIM-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 ( C-TAK1 ) : a novel role for PIM-1 at the G2/M cell cycle checkpoint [ J ]. 2004,279 ( 46 ) : 48319- 48328.
8Aho TL, Sandholm J, Peltola K J, et al. PIM-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site [ J ]. FEBS Lett, 2004,571 ( 1-3 ) : 43- 49.
9Xie Y,Xu K,Linn DE,et al. The 44-kDa PIM-1 kinase phospho- rylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells[J]. J Biol Chem,2008,283(6) :3349-3356.
10Lilly M,Sandholm J,Cooper JJ. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway [J]. Oncogene, 1999, 18 (27) :4022-4031.
4Ikegnchi M, Ueda T, Sakataui T, et al. Expression of surviviu messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol, 2002, 11: 33-40.
5Fox C J, Hammerman PS, Cinalli RM, et al. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev, 2003, 17: 1841-1854.
6Ghavami S, Hashemi M, Kadkhoda K, et al. Apoptosis in liver diseases-detection and therapeutic applications. Med Sci Monit, 2005, 11: RA337-345.
7Mikkers H, Nawijn M, Allen J, et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol, 2004, 24:6104-6115.
8Hammerman PS, Fox CJ, Bimbaum MJ, et al. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood, 2005, 105: 4477-4483.
9Fujii C, Nakamoto Y, Lu P, et al. Aberrant expression of serine/threoine kinase Pim 3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer, 2005,114 : 209-218.
10Li YY, Popivanova BK, Nagai Y, et al. Pim 3, a proto-oncogene with serine/ threonine kinase activity,is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res, 2006,66 : 6741-6747.
